2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist PROGRAM Session 1 Serous Neoplasia of the Ovary Mara H. Rendi, M.D., Ph.D. Endometrial Neoplasia, Subtypes, Mimics and Molecular Testing Mara H. Rendi, M.D., Ph.D. Session 2 Sex Cord Stromal Tumors of the Gynecologic Track Mara H. Rendi, M.D., Ph.D. Session 3 Problematic Issues in Breast Core Needle Biopsies Stuart J. Schnitt, M.D. Inflammatory and Reactive Lesions of the Breast Stuart J. Schnitt, M.D. Session 4 Evaluation of the Post-Neoadjuvant Chemotherapy Breast Specimen Stuart J. Schnitt, M.D. The Spectrum of Triple Negative Breast Cancer Stuart J. Schnitt, M.D. Pseudolymphomas Alejandro Ariel Gru, M.D. Session 5 Update in Cutaneous Lymphomas in the WHO Classification Alejandro Ariel Gru, M.D. Superficial Mesenchymal Tumors in the Pediatric Setting Alejandro Ariel Gru, M.D. Session 6 Cutaneous Histiocytic Neoplasms Alejandro Ariel Gru, M.D. The Challenging Melanocytic Lesions in the Pediatric Population Alejandro Ariel Gru, M.D. Session 7 Challenging Cervical Lesions of the Uterus Mara H. Rendi, M.D., Ph.D. Mesenchymal Tumors of the Uterus Mara H. Rendi, M.D., Ph.D. Session 8 Practical Placental Pathology Mara H. Rendi, M.D., Ph.D. Session 9 Problematic In Situ Lesions of the Breast Stuart J. Schnitt, M.D. Spindle Cell and Vascular Lesions of the Breast Stuart J. Schnitt, M.D. Session 10 The Continuing Dilemma of Ductal Carcinoma in Situ Stuart J. Schnitt, M.D. Molecular Testing & ER/PR, HER2 Guidelines in the Management of Patients with Breast Cancer Stuart J. Schnitt, M.D.

- Unbeatable Prices
- Secure Payments
- Accessible Worldwide
- Premium Quality
- Buy Once Access For Life
2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist
$109.00
2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist PROGRAM Session 1 Serous Neoplasia of the Ovary Mara H. Rendi, M.D., Ph.D. Endometrial Neoplasia, Subtypes, Mimics and Molecular Testing Mara H. Rendi, M.D., Ph.D. Session 2 Sex Cord Stromal Tumors of the Gynecologic Track Mara H. Rendi, M.D., Ph.D. Session 3 Problematic Issues in Breast Core Needle Biopsies Stuart J. Schnitt, M.D. Inflammatory and Reactive Lesions of the Breast Stuart J. Schnitt, M.D. Session 4 Evaluation of the Post-Neoadjuvant Chemotherapy Breast Specimen Stuart J. Schnitt, M.D. The Spectrum of Triple Negative Breast Cancer Stuart J. Schnitt, M.D. Pseudolymphomas Alejandro Ariel Gru, M.D. Session 5 Update in Cutaneous Lymphomas in the WHO Classification Alejandro Ariel Gru, M.D. Superficial Mesenchymal Tumors in the Pediatric Setting Alejandro Ariel Gru, M.D. Session 6 Cutaneous Histiocytic Neoplasms Alejandro Ariel Gru, M.D. The Challenging Melanocytic Lesions in the Pediatric Population Alejandro Ariel Gru, M.D. Session 7 Challenging Cervical Lesions of the Uterus Mara H. Rendi, M.D., Ph.D. Mesenchymal Tumors of the Uterus Mara H. Rendi, M.D., Ph.D. Session 8 Practical Placental Pathology Mara H. Rendi, M.D., Ph.D. Session 9 Problematic In Situ Lesions of the Breast Stuart J. Schnitt, M.D. Spindle Cell and Vascular Lesions of the Breast Stuart J. Schnitt, M.D. Session 10 The Continuing Dilemma of Ductal Carcinoma in Situ Stuart J. Schnitt, M.D. Molecular Testing & ER/PR, HER2 Guidelines in the Management of Patients with Breast Cancer Stuart J. Schnitt, M.D.








